Searchable abstracts of presentations at key conferences in endocrinology

ea0038p152 | Neoplasia, cancer and late effects | SFEBES2015

Phenotypic heterogeneity associated with proglucagon-expressing tumours is due to differential processing and secretion of proglucagon-derived peptides

Challis Ben , Albrechtsen Nicolai , Bansiya Vishakha , Burling Keith , Barker Peter , Hartmann Bolette , Gribble Fiona , O'Rahilly Stephen , Holst Jens , Simpson Helen

Context: Pancreatic neuroendocrine tumours (NETs) overexpressing glucagon are associated with phenotypic heterogeneity. Objective: To correlate clinical phenotype with detailed analysis of plasma levels of proglucagon-derived peptides (PGDPs) in subjects with proglucagon-expressing tumours using specific immunoassays and gel filtration profiles to elaborate molecular heterogeneity of PGDPs, before and after somatostatin analogues.Case 1: A 57 year old wo...

ea0067o24 | Oral Presentations | EYES2019

Proglucagon peptide family responses after RYGB surgery in obese patients with type 2 diabetes

Alexiadou Kleopatra , Cuenco Joyceline , Howard James W , Fleuret Matthieu , Behary Preeshila , Tharakan George , Albrechtsen Nicolai J Wewer , Holst Jens Juul , Pembroke Jason , Wheller Robert , Ahmed Ahmed R , Bloom Steve R , Tan Tricia M

Objective: Bariatric surgery is currently the most effective treatment for weight loss and diabetes remission. There are conflicting reports in the literature regarding the glucagon levels after RYGB surgery, likely due to cross-reactivity with oxyntomodulin and glicentin. The aim of this study was to characterize the proglucagon peptide family responses post-RYGB surgery in obese patients with type 2 diabetes using validated assays.Method: Nineteen obes...